Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$29.05 – $38.78
72% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83T | $1.67T | $1.61T | $2.28T | $2.62T | $2.39T | $2.59T | $2.44T |
| Cost of revenue | $1.63T | $1.46T | $1.38T | $1.83T | $2.11T | $1.97T | $2.12T | $2.01T |
| Gross profit | $195.11B | $206.92B | $233.18B | $453.43B | $510.15B | $413.27B | $469.34B | $432.10B |
| Gross margin | 10.7% | 12.4% | 14.5% | 19.9% | 19.5% | 17.3% | 18.1% | 17.7% |
| R&D | $1.05B | $1.21B | $1.47B | $1.08B | $1.81B | $3.58B | $0 | $0 |
| Operating income | $11.09B | $38.70B | $71.54B | $268.94B | $296.35B | $174.68B | $210.82B | $139.47B |
| EBITDA | $94.53B | $176.87B | $170.34B | $371.46B | $419.76B | $316.29B | $690.21B | $315.76B |
| Net income | −$44.50B | $31.13B | $139.23B | $1.01T | $1.01T | $228.60B | $477.71B | $213.08B |
| Net margin | -2.4% | 1.9% | 8.7% | 44.2% | 38.7% | 9.6% | 18.5% | 8.7% |
| EPS (diluted) | -87.93 | 61.46 | 274.85 | 1991.25 | 1993.71 | 468.13 | 1070.32 | 508.10 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $2.57T | $511.07 | $465.42–$543.60 | 1 |
| 2028 | $2.62T | $466.12 | $424.48–$495.78 | 1 |
| 2029 | $2.67T | $477.12 | $434.50–$507.48 | 1 |
| 2030 | $2.82T | $524.38 | $477.54–$557.74 | 1 |
Forward consensus · source: Financial Modeling Prep
NIPPON YUSEN KABUSHIK NEW
No one on the platform currently holds NYUKF.
No tracked institution reports a position in NYUKF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $100.0000 | |
| 2026-09-30 | $100.0000 | |
| 2026-03-31 | $25.0000 | 2026-06-18 |
| 2026-03-31 | $90.0000 | 2026-06-18 |
| 2025-09-30 | $115.0000 | 2025-12-03 |
| 2025-03-31 | $195.0000 | 2025-06-19 |
| 2024-09-30 | $130.0000 | 2024-12-02 |
| 2024-03-28 | $80.0000 | 2024-06-20 |
| 2023-09-29 | $60.0000 | 2023-12-01 |
| Execution date |
|---|
No one on the platform has traded NYUKF yet.
| +2.05% |
| $11.3B |
| — |
| OROVFOrient Overseas (International) Limited | $18.32 | +0.00% | $12.1B | — |
| OROVYOrient Overseas (International) Limited | $78.20 | +0.00% | $10.3B | — |
Source: Financial Modeling Prep · peers by sector/industry
| Ratio |
|---|
| 2022-09-29 | 3-for-1 |
| 2017-10-10 | 1-for-10reverse |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× earnings vs its 0.0× historical median P/E.
Fair value ≈ $33.75 · price $36.08 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.